Yomax
(2S,5R,6R)-6-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 33613.
Registration
- Applicants
- 1
- Registrations
- 2
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Actor Pharma (Pty) Ltd - Applicant | Yomax | 250 mg, 500 mg | 410687, 410688 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Yomax 250 MG EACH CAPSULE CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 250,0 mg | 250 mg | 41068741/20.1.2/0687 | Registered | Not determined | None |
| Yomax 500 MG EACH CAPSULE CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 500,0 mg | 500 mg | 41068841/20.1.2/0688 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.